share_log

Precision BioSciences Had Approximately $123.6M In Cash And Cash Equivalents As Of June 30, With Cash Runway Expected Into The Second Half Of 2026

Precision BioSciences Had Approximately $123.6M In Cash And Cash Equivalents As Of June 30, With Cash Runway Expected Into The Second Half Of 2026

截至6月30日,precision biosciences現金及現金等價物約爲12360萬美元,現金儲備預計可支持至2026年下半年。
Benzinga ·  08/01 20:03

Precision BioSciences Had Approximately $123.6M In Cash And Cash Equivalents As Of June 30, With Cash Runway Expected Into The Second Half Of 2026

截至6月30日,precision biosciences現金及現金等價物約爲12360萬美元,現金儲備預計可支持至2026年下半年。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論